Skip to content

The Biosimilars Forum

Ashburn, VA. EIN 81-0762544. Reported $2,117,500 of revenue for 2024 on its Form 990.

The IRS record

Registered name
THE BIOSIMILARS FORUM
As the IRS records it, which is how it appears in their own search.
Employer Identification Number
81-0762544
The identifier the IRS uses for this organization.
Recognized under
501(c)(6) — business league or chamber of commerce
The subsection of the code its exemption was granted under.
Recognized in
2016
The year of the IRS ruling.
Classification
Community Improvement and Capacity Building
NTEE code S41, assigned at registration.
Gifts to it
Contributions are not deductible
Whether the IRS treats a contribution to this organization as deductible.
Legal form
Corporation
How the organization is constituted, as recorded at registration.
Location of record
Ashburn, VA
The address the IRS holds, not necessarily where it operates.
Most recent filing
Form 990
For tax year 2024.

What it reported for 2024

$2,117,500
Total revenue
Contributions, grants, program service revenue and investment income.
$1,980,827
Total expenses
As reported on the return.
$2,722,624
Total assets, book value
At the end of the year, at what the organization paid for them.
0
People listed
Officers, directors, trustees, key employees and highest-paid employees.
not reported
Largest reported compensation
This organization reported paying nobody it listed.

Similar organizations

Other organizations in the same state and category as The Biosimilars Forum
OrganizationRevenue
Society for Human Resource Management$233,028,539
Americans for Prosperity$223,706,334
Consumer Technology Association$153,775,854
MPB Inc$90,608,196
FS-Isac Inc$50,893,979
Air-Conditioning Heating and Refrigeration Institute$42,063,292

This organization elsewhere

More in Virginia and under Community Improvement and Capacity Building. All organizations: nonprofits.

What this page cannot show

  • Everything here is what the organization told the IRS about itself. The IRS publishes returns as filed and does not audit them first.
  • The figures describe the most recent year on record, which is usually one to two years behind, and not the organization’s current position.
  • Nothing here says whether the organization does its work well, or how it spends what it raises beyond the totals on the form.

Something wrong? Tell us. Full method at methodology.

Sources

Data retrieved

The Biosimilars Forum: $2.1 million revenue (2024)